8 Recruiting Hepatocellular Carcinoma Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for hepatocellular carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Hepatocellular Carcinoma studiesPhase 1 / Phase 2 Studies for Hepatocellular Carcinoma
🔵 Active, Not Recruiting Phase1 / Phase2
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
📍 Hoag Hospital Newport Beach — Newport Beach, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
📍 Research Site — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
📍 The Kirklin Clinic of University of Alabama Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
📍 Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA — Philadelphia, Pennsylvania
View Study & Checklist ➔